Physician profile
Robert S Bear
NPI 1275534364
$12,949.29
in general payments reported to CMS, 2019-2025
52 companies · $2,235 in 2025
The $2,235 reported for 2025 was more than what 85% of Cardiovascular Disease providers received nationally (typical 2025 total: $433).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,104 · 2020: $1,137 · 2021: $1,841 · 2022: $3,042 · 2023: $2,007 · 2024: $1,584 · 2025: $2,235.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $5,826.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $5,825.65 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Novartis Pharmaceuticals Corporation | $2,030.81 | 2019-2025 | |
| Abbott Laboratories | $2,029.27 | 2019-2025 | Fortify Assura, Cardiomems, Mitraclip |
| Amgen INC. | $1,352.43 | 2019-2025 | Repatha, Repatha |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $754.60 | 2019-2025 | Lifevest |
| Boston Scientific Corporation | $646.80 | 2019-2025 | General - Therapies, Watchman Flx, Varithena Administration Pack |
| Impulse Dynamics (USA) INC. | $527.23 | 2021-2023 | Optimizer |
| Actelion Pharmaceuticals US, INC. | $454.09 | 2019-2025 | Opsumit, Uptravi |
| Merck Sharp & Dohme LLC | $451.31 | 2021-2025 | Verquvo, Winrevair, Capvaxive |
| Edwards Lifesciences Corporation | $439.99 | 2019-2025 | Sapien 3 Ultra Resilia |
| E.R. Squibb & Sons, L.L.C. | $429.31 | 2019-2025 | Camzyos, Eliquis |
| Pfizer INC. | $383.32 | 2019-2025 | |
| Novo Nordisk INC | $324.04 | 2021-2025 | Wegovy, Ozempic |
| Janssen Pharmaceuticals, INC | $312.94 | 2019-2024 | Xarelto |
| Boehringer Ingelheim Pharmaceuticals, INC. | $304.49 | 2019-2025 | Jardiance |
| Astrazeneca Pharmaceuticals Lp | $300.81 | 2019-2025 | Farxiga, Wainua, Brilinta |
Show all 52 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Biotronik INC. | $248.63 | 2019-2022 | |
| Kestra Medical Technology Services, INC. | $243.72 | 2022-2024 | Assure Wcd |
| Bardy Diagnostics, INC. | $160.00 | 2020-2021 | |
| Cleerly, INC. | $149.75 | 2025 | Cleerly Labs, Cleerly Ischemia |
| Sanofi-Aventis U.S. LLC | $147.05 | 2019-2024 | |
| Kiniksa Pharmaceuticals, Ltd. | $116.88 | 2022-2023 | Arcalyst |
| Alnylam Pharmaceuticals INC. | $109.82 | 2022-2025 | Amvuttra |
| United Therapeutics Corporation | $99.42 | 2022-2023 | Tyvaso, Orenitram |
| Heartflow, INC. | $90.82 | 2024 | |
| Amarin Pharma, INC. | $88.35 | 2020-2022 | |
| Bridgebio Pharma, INC. | $84.87 | 2025 | Attruby |
| Regeneron Healthcare Solutions, INC. | $62.80 | 2019 | |
| Bayer Healthcare Pharmaceuticals INC. | $61.13 | 2023-2025 | |
| Kiniksa Pharmaceuticals International, Plc | $48.01 | 2024 | Arcalyst |
| Cvrx, INC. | $47.82 | 2024 | Barostim Neo System |
| Vivaquant INC, Dba Rhythm Express | $39.10 | 2024 | Rhythm Express |
| Innovation Technologies INC | $35.52 | 2024 | Irrisept |
| Cardiva Medical, INC. | $34.62 | 2025 | Cardiva Vascade Mvp Vvcs 6-12f |
| Lexicon Pharmaceuticals, INC. | $30.05 | 2024 | |
| Kowa Pharmaceuticals America, INC. | $28.93 | 2020-2021 | |
| Abiomed | $25.73 | 2020 | |
| Organogenesis INC. | $24.08 | 2023 | Puraply |
| Astellas Pharma US INC | $22.17 | 2021 | |
| Inspire Medical Systems, INC. | $21.91 | 2024 | Inspire |
| Itamar Medical INC | $18.21 | 2021-2023 | Watchpatone |
| Endotronix, INC. | $17.81 | 2025 | Cordella Pulomonary Artery Pressure Sensor |
| Esperion Therapeutics, INC. | $17.71 | 2021 | |
| Medtronic, INC. | $16.40 | 2023 | Endurant Iis |
| Csl Behring | $15.90 | 2019 | |
| W. L. Gore & Associates, INC. | $14.69 | 2025 | Excluder Conformable Aaa Endoprosthesis With Active Control |
| Tactile Systems Technology INC | $14.00 | 2021 | |
| Aop Health US, LLC | $13.92 | 2025 | Rapiblyk |
| Irhythm Technologies, INC. | $13.91 | 2020 | |
| Glaxosmithkline, LLC. | $13.87 | 2025 | Shingrix, Arexvy |
| Chiesi USA, INC. | $13.58 | 2020 | |
| Medtronic Vascular, INC. | $10.99 | 2020 | |
| Thrombolex, INC. | $5.68 | 2024 | Bashir Endovascular Catheter |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Robert Bear listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.